Jonathan M. Hopper
Net Worth
Last updated:
What is Jonathan M. Hopper net worth?
The estimated net worth of Dr. Jonathan M. Hopper is at least $9,328,936 as of 2 Dec 2024. He owns shares worth $2,111,279 as insider, has earned $4,599,257 from insider trading and has received compensation worth at least $2,618,400 in Vericel Corporation.
What is the salary of Jonathan M. Hopper?
Dr. Jonathan M. Hopper salary is $523,680 per year as Chief Medical Officer in Vericel Corporation.
How old is Jonathan M. Hopper?
Dr. Jonathan M. Hopper is 63 years old, born in 1962.
What stocks does Jonathan M. Hopper currently own?
As insider, Dr. Jonathan M. Hopper owns shares in one company:
Company | Title | Shares | Price per share | Total value |
---|---|---|---|---|
Vericel Corporation (VCEL) | Chief Medical Officer | 58,371 | $36.17 | $2,111,279 |
What does Vericel Corporation do?
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for the repair of symptomatic, and single or multiple full-thickness cartilage defects of the knee; and Epicel, a permanent skin replacement humanitarian use device for the treatment of adult and pediatric patients with deep-dermal or full-thickness burns. Its preapproval stage product is NexoBrid, a registration-stage biological orphan product for eschar removal in adults with deep partial-thickness and/or full-thickness thermal burns. The company was formerly known as Aastrom Biosciences, Inc. Vericel Corporation was incorporated in 1989 and is headquartered in Cambridge, Massachusetts.
Jonathan M. Hopper insider trading
Vericel Corporation
Dr. Jonathan M. Hopper has made 13 insider trades between 2020-2024, according to the Form 4 filled with the SEC.
The largest trade he's ever made was exercising 43,264 units of VCEL stock on 21 Dec 2020. As of 2 Dec 2024 he still owns at least 58,371 units of VCEL stock.
Vericel key executives
Vericel Corporation executives and other stock owners filed with the SEC:
- Dr. Jonathan M. Hopper (63) Chief Medical Officer
- Mr. Dominick C. Colangelo Esq. (61) Chief Executive Officer, Pres & Director
- Mr. Michael Halpin (64) Chief Operating Officer
- Mr. Sean C. Flynn (51) Vice President, Gen. Counsel & Sec.